SGO

SISTER: All for one and one for all?

Group peer support alone does not improve treatment completion for Black women with high‑risk endometrial cancer, but a one-on-one human connection did.

Emily O'Brien, MD

A Clearer Signal in Ovarian Cancer

Screenshot 2026 04 11 At 7 18 33 Am

Watch | SGO 2026 Annual Meeting Opening Ceremony

Kelsey Wood (left) and Kim Hoarle, MBA, CAE

Where Science Meets Community

Smile, You’re on Camera!

See Photo Gallery

ROSELLA Trial: Beyond Biomarkers

Trial results suggest a new standard in platinum-resistant ovarian cancer (PROC) therapy.

Amanda Nickles Fader, MD

Chemotherapy Followed by Endocrine Therapy Continues for Treatment of Low Grade Serous Ovarian Cancer

New science addresses a key clinical question about treating advanced-stage LGSOC.

Explore our DXd ADC Technology

Explore our DXd ADC Technology

At Daiichi Sankyo, we aim to expand the potential of antibody drug conjugates (ADCs) through our proprietary technology.

Karen Lu, MD

Welcome to the SGO 2026 Annual Meeting on Women’s Cancer

SGO President Karen Lu, MD, reveals the three key components of this year’s theme.

Ana Oaknin, MD, PhD

One-Two Punch for Gynecologic Oncology

Antibody–drug conjugate shows promising response rates in difficult‑to‑treat ovarian and endometrial cancer.

Matthew A. Powell, MD

Hope on the Horizon

Phase 3 RUBY trial demonstrated positive outcomes for patients with primary advanced or recurrent endometrial cancer.

Explore our DXd ADC Technology

Explore our DXd ADC Technology

Step into new possibilities

Step into new possibilities

Click here to learn more about Avmapki Fakzynja Co-Pack

Click here to learn more about Avmapki Fakzynja Co-Pack

Sgo April 11th Selects 24

A Perfect Place to Lounge and Lean in

The Exhibit Hall’s Fellows’ Lounge provides young members with a comfortable place to network, organize, and recharge.

Gottfried Konecny, MD

Shifting the MIRV Timeline

New study highlights the possibilities of MIRV plus carboplatin in platinum-sensitive ovarian cancer.

Abigail Zamorano, MD, MPHS (left), and Julie Sammouri, MD

Cost-Saving and High Impact Primary HPV Testing

Primary HPV testing could cut costs and improve cervical cancer prevention in underserved communities.

Oleksandra Dzyubak, MD

The Move Toward Personalized Fertility Sparing Treatment

New study identifies molecular predictors of response to such therapies for endometrial cancer.

Ginger J. Gardner, MD, FACOG

Building a Brighter Future

The Foundation for Women’s Cancer reflects on the success of 35 years and prepares for the opportunities ahead.

Madison Kieffer, MD (left), and Katelyn Tondo-Steele, DO

Can Artificial Intelligence Save Real Time?

Large language models could be a valuable tool in documentation and support for outpatient visits.

Pamela T. Soliman, MD, MPH (left), and Christine Walsh, MD, MS

Breakthrough Science, Bold Conversations, and New Educational Experiences

Getty Images 1400275887

Accreditation and Evaluations for CE

Screenshot 2026 04 02 At 10 03 21 Am

Bill Cliby, MD, Accepts the President's Award

Screenshot 2026 03 31 At 9 41 47 Am

Empowering Teams in San Juan

Screenshot 2026 03 31 At 9 41 37 Am

Embracing Change in San Juan

Screenshot 2026 03 28 At 10 13 09 Am

Explore the SGO 2026 Annual Meeting Schedule

Screenshot 2026 03 28 At 9 42 23 Am

Advancing Science in San Juan

Sgo April 11th Selects 32

SGO 2026 Annual Meeting on Women’s Cancer Photo Gallery

San Juan, Puerto Rico

Save the date for SGO 2026 Annual Meeting on Women’s Cancer

masterclass

Renew or Become a Member of SGO

eLearning

eLearning for the Real World

52770438226 5e240f030b O Looking For A Job

Looking for a Job?